Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Progression-free survival prolonged in Avastin study in colorectal cancer

Dec. 1, 2003

Enrollment completed in STELLAR 3 pivotal trial of Xyotax

Dec. 1, 2003

Antiangiogenic and antiproliferative effects described for AP-23573 in tumor cells

Dec. 1, 2003

Plenaxis receives FDA approval

Nov. 28, 2003

Introgen and SWOG to evaluate Advexin plus surgery in phase II trial

Nov. 28, 2003

Antisoma and EMD Lexigen create immunocytokine fusion protein

Nov. 28, 2003

Preliminary phase I results on EKB-569 for advanced colorectal cancer

Nov. 28, 2003

ET-743 is associated with changes in the gene expression of sarcoma cells

Nov. 28, 2003

Metvix approved in Switzerland

Nov. 27, 2003

Novel EGFR inhibitors under study at Boehringer Ingelheim

Nov. 27, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...